colab
we are not here to fit in
.png)
designed for
systems change
the cancer collaborative is a catalyst for change — where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
HOW WE WORK
it all starts with co.
no one can fix a cancer system alone. and we don't intend to
connect
patients, clinicians, policymakers and industry, in the same room
collect
lived experience gathered as evidence: the delays, gaps and inequities in the system to shape appropriate responses
colab-orate
when the people who have to make change happen help design it, it doesn't get fixed from one side and break somewhere else
codesign
mapping the barriers together - so everyone is working from the same understanding of what's actually going wrong and why
COLLABORATE
add your voice, now
measuring the broader impact of patient advocacy
a survey designed to assess how well pharmaceutical, biotech, and diagnostics companies understand the work of patient and advocacy organizations, and how that work is integrated into company strategy. the data will be published as an industry benchmark report . responses are anonymous and take approximately 10 minutes. the report will be available to participating organizations and online.
rethinking how we define value in HTA
biomarker awareness day
#KNOWVEMBER
precision
oncology
awareness
month
a month dedicated to raising awareness about precision oncology and biomarkers and a year round hub for patients, clinicians, decision makers and industry
get involved
share your story. share a resource. share the campaign
building a blueprint for precision oncology in canada
DATES TO BE ANNOUNCED
a co.laboratory to design Canada's precision oncology stratgey
COLABORATORY. SYSTEM RESET 26
three places the system breaks
where change can actually happen.
this is where the work happens. we bring patients, clinicians, policymakers and industry together around the toughest access problems in cancer care, and build the solutions with them, not for them
co.laterals
THE LIBRARY
colab developped papers, briefs, notes. if we wrote it you'll find it here. free to read, share and use
ASCO 2026
practice changing data from the ASCO 2026 annual meeting
JUNE 2026
priorités stratégiques et recommandations en matière d’accès au diagnostic et d’innovation du système de santé
priorités stratégiques et recommandations en matière d’accès au diagnostic et d’innovation du système de santé
JUIN 2025
the cancer paradox. investment. spending & the ROI we leave on the table
over the past 25 years canada has invested 4B$ into cancer research - it will spend that much treating cancer over the next 5 weeks.
APRIL 2026
strategic priorities and recommendations for diagnostic access and system innovation in québec
strategic priorities and recommendations on diagnostic access and system innovation
JUNE 2025
RETHINKING HTA. DO WE NEED A MORE PATIENT CENTRIC APPROACH TO HTA. 2025
this paper explores why current HTA frameworks fall short in reflecting patient defined value and calls for a structural shift toward truly patient centric assessment. offering a roadmap to embed lived experience, equity, and partnership across the HTA lifecycle.
JULY 2025
co.llective
IN THE PRESS
co(mmentary)
ON SUBSTACK
sharp takes on what's moving in cancer policy, straight to your inbox.
january 2026
rethinking hta: do we need a patient centric framework
december 2025
building a patient centric cancer system in canada
april 2025
your health. your vote. your voice
co-nnect with us. we are always building something
ABBVIE ASTRA ZENECA CBQA EISAI GENOME CANADA GILEAD GSK KITE JJIM MERCK ROCHE ROCHE DIAGNOSTICS SOUTHLAKE HOSPITAL THE OTTAWA HOSPITAL
JJIM MERCK ROCHE ROCHE DIAGNOSTICS SOUTHLAKE HOSPITAL THE OTTAWA HOSPITAL ABBVIE ASTRA ZENECA CBQA EISAI GENOME CANADA GILEAD GSK KITE
SOUTHLAKE HOSPITAL THE OTTAWA HOSPITAL ABBVIE ASTRA ZENECA CBQA EISAI GENOME CANADA GILEAD GSK KITE JJIM MERCK ROCHE ROCHE DIAGNOSTICS
COLAB
